Rural patients who identify as Black experience higher rates of death and amputation from diabetic foot ulcer
Rural patients who identify as Black are at sharply increased risk of death or leg amputation due to diabetic foot ulcers, according to a new study from the University of Wisconsin School of Medicine and Public Health that analyzed national data on patient outcomes.
Wisconsin Registry for Alzheimer’s Prevention marks 20th anniversary
November marks a significant scientific milestone for the Wisconsin Registry for Alzheimer’s Prevention (WRAP) study at the University of Wisconsin School of Medicine and Public Health. It is the 20th anniversary of a groundbreaking study that is advancing the field of Alzheimer’s research here in Wisconsin and internationally.
UW School of Medicine and Public Health honors Native American Heritage Month
November marks Native American Heritage Month in the United States and the University of Wisconsin School of Medicine and Public Health reaffirms its commitment to advancing the health of Native Americans and increasing the representation of Native Americans in the health care workforce.
Hospital socioeconomic status, strain may increase death rate among ICU patients with COVID-19
Researchers at the University of Wisconsin School of Medicine and Public Health used hospital data from patients with COVID-19 admitted to intensive care units across the nation to identify factors linked to higher mortality rates within 28 days of admission.
UW Health treats first patient in U.S. with investigational cell therapy for heart disease
Appleton resident Donald Krause became the first patient in the country last week to undergo an investigational cell therapy for a debilitating heart condition called chronic myocardial ischemia (CMI).
UW study examines allergic reactions to COVID-19 vaccines
Researchers from the UW School of Medicine and Public Health are seeking participants for a clinical study that examines whether the mRNA COVID-19 vaccines (Pfizer/BioNTech and Moderna) pose an increased risk for allergic reactions in individuals who are already considered “highly allergic.”
UW shows strong presence at Alzheimer’s Association International Conference
The world’s largest and most prestigious Alzheimer’s disease conference is underway this week, and UW Alzheimer’s disease researchers are attending in high numbers, leading several important discussions.
Dr. Ann Sheehy named a Robert Wood Johnson Foundation Health Policy Fellow
In recognition of her expertise as a physician and work addressing health equity issues, Ann Sheehy, MD, MS, associate professor of medicine and chief of the Division of Hospital Medicine in the Department of Medicine, was named a Robert Wood Johnson Foundation Health Policy Fellow by The National Academy of Medicine for the class of 2021-22.
Michael Fiore named recipient of campus Hilldale Award
University of Wisconsin School of Medicine and Public Health professor of medicine Michael Fiore, MD, MPH, MBA, has been named the recipient of the 2021 Hilldale Award for Biological Sciences. Fiore is the director of the University of Wisconsin Center for Tobacco Research and Intervention.
Alzheimer’s study finds link between living in disadvantaged neighborhoods and brain shrinkage, declining brain function
In a newly published study, researchers at the University of Wisconsin School of Medicine and Public Health report finding a correlation between living in neighborhoods with the fewest social and economic advantages and experiencing changes in brain structure and function that are characteristic of Alzheimer’s diseases and related dementias.
New UW study examines immune response to COVID-19 vaccine in patients with inflammatory bowel disease
A new study at the University of Wisconsin School of Medicine and Public Health is looking at the immune response to COVID-19 vaccines in patients with inflammatory bowel disease (IBD). Enrollment is open now for patients who fit the criteria.
Nataliya Uboha named faculty leader of Cancer Therapy Discovery and Development (CTD2) at UW Carbone Cancer Center
Nataliya Uboha, MD, PhD, has been selected to lead the Cancer Therapy Discovery and Development (CTD2) program at the University of Wisconsin Carbone Cancer Center.